Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-22-065840
Filing Date
2022-10-24
Accepted
2022-10-24 16:18:08
Documents
6
Effectiveness Date
2022-10-24

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea167481-s8_chinapharma.htm S-8 82494
2 OPINION OF FLANGAS LAW GROUP (REGARDING VALIDITY OF COMMON STOCK BEING REGISTERE ea167481ex5-1_chinapharma.htm EX-5.1 10193
3 CONSENT OF B F BORGERS CPA PC ea167481ex23-2_chinapharma.htm EX-23.2 2548
4 FILING FEE TABLE ea167481ex-fee_chinapharma.htm EX-FILING FEES 45140
5 GRAPHIC ex23-1_001.jpg GRAPHIC 14462
6 GRAPHIC ex23-2_001.jpg GRAPHIC 19785
  Complete submission text file 0001213900-22-065840.txt   189142
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-267989 | Film No.: 221326246
SIC: 2834 Pharmaceutical Preparations